Strs Ohio Bluebird Bio, Inc. Transaction History

Strs Ohio

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$4.07 - $10.6 $31,339 - $81,620	-7,700 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$18.04 - $22.09 $138,908 - $170,093	7,700 New	7,700 $246,000
Q3 2018 Oct 19, 2018	SELL	$88.86 - $117.49 $102,544 - $135,583	-1,154 Closed	0 $0
Q2 2018 Aug 06, 2018	SELL	$99.64 - $127.59 $1 Million - $1.28 Million	-10,046 Reduced 89.7%	1,154 $181,000
Q1 2018 Apr 20, 2018	BUY	$105.8 - $150.94 $126,960 - $181,128	1,200 Added 12.0%	11,200 $1.91 Million
Q4 2017 Jan 23, 2018	BUY	$81.25 - $130.7 $89,375 - $143,770	1,100 Added 12.36%	10,000 $1.78 Million
Q3 2017 Oct 23, 2017	BUY	$57.74 - $91.42 $513,886 - $813,638	8,900	8,900 $1.22 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.